Qifeng Yang
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies 57
- Cancer-related molecular mechanisms research 50
- MicroRNA in disease regulation 40
- Oncology top 0.5%
- Cancer-related Molecular Pathways 31
- Pathology and Forensic Medicine top 0.5%
- Breast Lesions and Carcinomas 42
- Cancer Mechanisms and Therapy 41
- Molecular Biology top 0.5%
- Circular RNAs in diseases 40
- RNA modifications and cancer 37
- Immunology top 2%
- Co-authors
- Bruce G. HafftyNing ZhangHanwen ZhangYiran LiangXiaojin SongMeena S. MoranYaming LiBing Chen
- Journals
- International Journal of Radiation Oncology*Biology*Physics (13 papers)PLoS ONE (11 papers)International Journal of Oncology (10 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Qifeng Yang
343 papers receiving 12.8k citations
Hit Papers
Peers
Comparison fields: 5 of 174
- Cancer Research 5.9k
- Oncology 4.4k
- Pathology and Forensic Medicine 2.2k
- Molecular Biology 7.4k
- Immunology 1.1k
Countries citing papers authored by Qifeng Yang
This map shows the geographic impact of Qifeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qifeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qifeng Yang more than expected).
Fields of papers citing papers by Qifeng Yang
This network shows the impact of papers produced by Qifeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qifeng Yang. The network helps show where Qifeng Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qifeng Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 7 | |
| 6 | 2023 | 2 | |
| 7 | 2019 | 107 | |
| 8 | circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancerbreakdown → | 2019 | 340 |
| 9 | 2018 | 10 | |
| 10 | 2015 | 77 | |
| 11 | 2015 | 47 | |
| 12 | 2014 | 35 | |
| 13 | 2010 | 15 | |
| 14 | 2005 | 7 | |
| 15 | 2005 | 6 | |
| 16 | Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up. | 2003 | 110 |
| 17 | Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer. | 2003 | 66 |
| 18 | Loss of Msh2 is not associated with FHIT deletion in breast carcinomas. | 2003 | 3 |
| 19 | The Fragile Histidine Triad gene and breast cancer. | 2002 | 8 |
| 20 | Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma. | 2001 | 27 |
About Qifeng Yang
Qifeng Yang is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 359 papers that have together received 13.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (57 papers), Cancer-related molecular mechanisms research (50 papers), Breast Lesions and Carcinomas (42 papers), Cancer Mechanisms and Therapy (41 papers), MicroRNA in disease regulation (40 papers), Circular RNAs in diseases (40 papers), RNA modifications and cancer (37 papers) and Cancer-related Molecular Pathways (31 papers). The work is most often cited by research in Cancer Research (5.9k citations), Oncology (4.4k citations) and Pathology and Forensic Medicine (2.2k citations). Qifeng Yang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Bruce G. Haffty, Ning Zhang, Hanwen Zhang, Yiran Liang, Xiaojin Song, Meena S. Moran, Yaming Li, Bing Chen, Xiaolong Wang and Xiaoyan Li. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, PLoS ONE, International Journal of Oncology, Oncotarget and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.